Bevacizumab (Avastin)

Bevacizumab is a humanized monoclonal antibody that was the first FDA approved therapy designed to inhibit angiogenesis. This paper will review the mechanism of action and clinical role of this antiangiogenic agent.

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:AJNR Am J Neuroradiol
Yazar: Mukherji, S.K.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Neuroradiology 2010
Konular:
Pharmacology Vignette
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7964163/
https://ncbi.nlm.nih.gov/pubmed/20037132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A1987
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller